Shinsei Bank said on Wednesday it will cancel plans to introduce a poison pill defence aimed at blocking SBI Holdings Inc’s $1.1 billion bid, paving the way for the online financial conglomerate to take effective control of the lender.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
